Literature DB >> 32047911

Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia.

Amy Steele1, Ramon Gonzalez2, Juan C Garbalosa3, Keith Steigbigel3, Tania Grgurich2, Erika J Parisi4, Richard S Feinn1, Steven M Tommasini5, Carolyn M Macica1.   

Abstract

CONTEXT: X-Linked hypophosphatemia (XLH) is a lifelong metabolic disease with musculoskeletal comorbidities that dominate the adult clinical presentation.
OBJECTIVE: The adult XLH disorder has yet to be quantified on the basis of the physical and functional limitations that can affect activities of daily living. Our goal was to report the impact of the musculoskeletal manifestations on physical function. DESIGN AND
SETTING: Musculoskeletal function was evaluated by validated questionnaires and in an interdisciplinary clinical space where participants underwent full-body radiologic imaging, goniometric range of motion (ROM) measurements, general performance tests, and kinematic gait analysis. PATIENTS: Nine adults younger than 60 years with a diagnosis of XLH and self-reported musculoskeletal disability, but able to independently ambulate, were selected to participate. Passive ROM and gait analysis were also performed on age-approximated controls to account for differences between individual laboratory instrumentation.
RESULTS: Enthesophytes, degenerative arthritis, and osteophytes were found to be consistently bilateral and diffusely present at the spine and synovial joints across participants, with predominance at weight-bearing joints. Passive ROM in adults with XLH was decreased at the cervical spine, hip, knee, and ankle compared to controls. Gait analysis relative to controls revealed increased step width, markedly increased lateral trunk sway, and physical restriction at the hip, knees, and ankle joints that translated into limitations through the gait cycle.
CONCLUSIONS: The functional impact of XLH musculoskeletal comorbidities supports the necessity for creating an interprofessional health-care team with the goal of establishing a longitudinal plan of care that considers the manifestations of XLH across the lifespan. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  X-linked hypophosphatemia; degenerative arthritis; enthesopathy; gait analysis; osteophyte; range of motion

Mesh:

Year:  2020        PMID: 32047911     DOI: 10.1210/clinem/dgaa064

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  An Evidence-based Physical Therapy Prescription for Adults With X-linked Hypophosphatemia.

Authors:  Karthik Kanamalla; Rebekah Fuchs; Casey Herzog; Keith D Steigbigel; Carolyn M Macica
Journal:  J Endocr Soc       Date:  2022-06-18

Review 2.  Burosumab for Pediatric X-Linked Hypophosphatemia.

Authors:  Erik A Imel
Journal:  Curr Osteoporos Rep       Date:  2021-05-10       Impact factor: 5.163

Review 3.  Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.

Authors:  Michaël R Laurent; Jean De Schepper; Dominique Trouet; Nathalie Godefroid; Emese Boros; Claudine Heinrichs; Bert Bravenboer; Brigitte Velkeniers; Johan Lammens; Pol Harvengt; Etienne Cavalier; Jean-François Kaux; Jacques Lombet; Kathleen De Waele; Charlotte Verroken; Koenraad van Hoeck; Geert R Mortier; Elena Levtchenko; Johan Vande Walle
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-19       Impact factor: 5.555

4.  Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia.

Authors:  Gabriel T Mindler; Andreas Kranzl; Alexandra Stauffer; Roland Kocijan; Rudolf Ganger; Christof Radler; Gabriele Haeusler; Adalbert Raimann
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-27       Impact factor: 5.555

5.  Persistent Lower Limb Deformities Despite Amelioration of Rickets in X-Linked Hypophosphatemia (XLH) - A Prospective Observational Study.

Authors:  Gabriel T Mindler; Alexandra Stauffer; Andreas Kranzl; Stefan Penzkofer; Rudolf Ganger; Christof Radler; Gabriele Haeusler; Adalbert Raimann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 6.055

6.  Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data.

Authors:  Muhammad Kassim Javaid; Leanne Ward; Rafael Pinedo-Villanueva; Angela J Rylands; Angela Williams; Karl Insogna; Erik A Imel
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

7.  Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study.

Authors:  Matteo Scorcelletti; Serhan Kara; Jochen Zange; Jens Jordan; Oliver Semler; Eckhard Schönau; Jörn Rittweger; Alex Ireland; Lothar Seefried
Journal:  Osteoporos Int       Date:  2022-04-18       Impact factor: 5.071

8.  FGF receptor inhibitor BGJ398 partially rescues osteoarthritis-like phenotype in older high molecular weight FGF2 transgenic mice via multiple mechanisms.

Authors:  Marja M Hurley; J Douglas Coffin; Thomas Doetschman; Christina Valera; Kai Clarke; Liping Xiao
Journal:  Sci Rep       Date:  2022-09-24       Impact factor: 4.996

9.  Giving Credence to the Experience of X-Linked Hypophosphatemia in Adulthood: An Interprofessional Mixed-Methods Study.

Authors:  Melissa Hughes; Carolyn Macica; Catherine Meriano; Maya Doyle
Journal:  J Patient Cent Res Rev       Date:  2020-04-27

10.  Enthesopathy, Osteoarthritis, and Mobility in X-linked Hypophosphatemia1.

Authors:  Erik A Imel
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.